Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Endocrine Testing Market?

There has been a robust growth in the size of the endocrine testing market in the recent past. The value of the market is projected to increase from $2.55 billion in 2024 to $2.79 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.6%. The remarkable growth during the historical period can be ascribed to advancements such as the identification of hormones and endocrine pathways, standardization of diagnostic tests, public health campaigns, and assertive patient involvement and empowerment.

In the coming years, the endocrine testing market is predicted to witness substantial growth. The market is projected to increase to $3.89 billion in 2029, with a compound annual growth rate (CAGR) of 8.7%. The growth anticipated in the forecast period can be ascribed to factors such as the escalating prevalence of endocrine disorders, heightened defense expenditure, growing elderly population, increased recognition and early diagnostic practices, and enhanced awareness. Predominant trends during the forecast period comprise progress in biomarker detection, the fusion of omics technologies, the implementation of artificial intelligence and machine learning, quality assurance and standardization, and coordinated research and translational medicine.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15562&type=smp

What Underlying Factors Are Supporting The Endocrine Testing Market Growth?

The increasing incidence of diabetes is anticipated to drive the expansion of the endocrine testing market. Diabetes is a cluster of disorders leading to elevated blood sugar (glucose) levels. Unhealthy food habits, lack of physical activity, inherited tendencies, and a growing elderly population are contributing to a surge in diabetes cases. Various tests, such as hemoglobin A1c, fasting plasma glucose, and C-peptide, are employed in endocrine testing to diagnose diabetes, monitor glucose concentrations, and evaluate insulin production and sensitivity. For example, according to the National Health Service, UK, the figures for diabetes among individuals below 40 surged from 173,166 in 2022 to 216,440 in 2023. This drastic rise underscores an alarming pattern in this demographic. It signifies a swift increase in diabetes prevalence among the younger generation, contributing to the growth of the endocrine testing market.

How Does The Endocrine Testing Market Differ By Segment?

The endocrine testingmarket covered in this report is segmented –

1) By Test Type: Estradiol (E2) Test; Follicle Stimulating Hormone (FSH) Test; Human Chorionic Gonadotropin (hCG) Hormone Test; Luteinizing Hormone (LH) Test; Dehydroepiandrosterone Sulfate (DHEAS) Test; Progesterone Test; Testosterone Test; Thyroid Stimulating Hormone (TSH) Test; Prolactin Test; Other Types

2) By Technology: Tandem Mass Spectrometry; Immunoassay; Monoclonal And Polyclonal Antibody Technologies; Sensor Technology; Clinical Chemistry; Other Technologies

3) By End-User: Hospitals; Clinical Laboratories; Diagnostic Centers; Other End-Users

Subsegments:

1) By Estradiol (E2) Test: Serum Estradiol Test; Urinary Estradiol Test

2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test; FSH Urine Test

3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test; Qualitative hCG Test

4) By Luteinizing Hormone (LH) Test: LH Serum Test; LH Urine Test

5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test; Saliva DHEAS Test

6) By Progesterone Test: Serum Progesterone Test; Urinary Progesterone Test

7) By Testosterone Test: Free Testosterone Test; Total Testosterone Test

8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test; TSH Saliva Test

9) By Prolactin Test: Serum Prolactin Test; Plasma Prolactin Test

10) By Other Types: Cortisol Test; Insulin Test; Growth Hormone (GH) Test; Aldosterone Test

What New Opportunities Are Emerging From Trends In The Endocrine Testing Market?

Leading businesses in the endocrine testing market are focusing on the development of point-of-care testing solutions. These solutions improve the ease and effectiveness of endocrine disorder diagnosis. The speed of producing results from point-of-care testing is beneficial for swift diagnosis and control of heart failure in patients experiencing symptoms like breathlessness and tiredness. For example, Roche Holding AG, a Pharmaceutical firm based in Switzerland, introduced a point-of-care NT-proBNP test in India in April 2024. This test is exclusively for diabetes patients prone to cardiovascular conditions like heart failure (HF). The test supports early detection and intervention, permitting clinicians to identify T2D patients at high risk and start necessary treatment discussions on time. This early intervention improves patient outcomes and enhances their well-being.

Who Are The Global Leaders Steering The Endocrine Testing Market Forward?

Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/endocrine-testing-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Endocrine Testing Market?

North America was the largest region in the endocrine testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15562&type=smp

Browse Through More Reports Similar to the Global Endocrine Testing Market 2025, By The Business Research Company

Endoscopy Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/endoscopy-devices-and-equipment-global-market-report

Endoscope Reprocessing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/endoscope-reprocessing-global-market-report

Endodontics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/endodontics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model